Clinical trial
Phase III Study Analyzing the Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
NCT00400387 is registered in ClinicalTrials.gov with University of Jena as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study Analyzing the Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
- Lead sponsor
- University of Jena
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- April 30, 2013
- Enrollment
- 449 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.